Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Lath formation mechanisms and twinning as lath martensite substructures in an ultra low-carbon iron alloy.

Scientific reports·2018
Same author

Diagnostic accuracy of plasma atrial natriuretic peptide concentrations in cats with and without cardiomyopathies.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2018
Same author

Storage stability of serum formulations containing ofloxacin for autologous serum eardrop therapy.

Die Pharmazie·2018
Same author

Measurement and comparison of individual external doses of high-school students living in Japan, France, Poland and Belarus-the 'D-shuttle' project.

Journal of radiological protection : official journal of the Society for Radiological Protection·2015
Same author

PET study in a patient with spinocerebellar degeneration before and after long-term administration of thyrotropin releasing hormone.

Behavioural neurology·2014
Same author

A Japanese family with Machado-Joseph disease characterized by initial emaciation and myoclonus.

European journal of neurology·2013

相关实验视频

Updated: Jul 18, 2026

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
16:57

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

Published on: February 14, 2012

在帕金森病中,化学敏感性和呼吸障碍的感知受损.

H Onodera, S Okabe, Y Kikuchi

    Lancet (London, England)
    |November 21, 2000
    PubMed
    概括

    患有帕金森病的患者对低氧水平 (低氧) 的敏感性降低,呼吸困难的感觉变得麻木. 这种减弱的缺氧反应可能会导致早期帕金森病的呼吸衰竭恶化.

    科学领域:

    • 神经学 神经学
    • 呼吸系统医学 呼吸系统医学
    • 身体生理学 身体生理学

    背景情况:

    • 帕金森病 (PD) 与呼吸道并发症有关,可能与化学感觉受损有关.
    • 这项研究调查了早期PD患者的低氧性和高性化学敏感性和呼吸障碍感知.

    更多相关视频

    Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
    08:09

    Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

    Published on: January 7, 2014

    Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
    06:45

    Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

    Published on: October 4, 2021

    相关实验视频

    Last Updated: Jul 18, 2026

    MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
    16:57

    MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

    Published on: February 14, 2012

    Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
    08:09

    Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

    Published on: January 7, 2014

    Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
    06:45

    Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

    Published on: October 4, 2021